drugset / Trial / NCT01645800

Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

NCT01645800

Phase 4 Completed 408 enrolled Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to assess the effectiveness in preventing exacerbation of 52 weeks lysozyme administration in patients with COPD.

Timeline

Start
2012-08
Primary completion
2015-01
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lysozyme Unknown 90 mg